Literature DB >> 22993616

siRNA-mediated knockdown of VEGF-A, VEGF-C and VEGFR-3 suppresses the growth and metastasis of mouse bladder carcinoma in vivo.

Feng Wang1, Hui-Ming Li, Hui-Ping Wang, Jia-Lie Ma, Xia-Fang Chen, Fang Wei, Miao-Ying Yi, Qian Huang.   

Abstract

The growth of solid tumors is highly dependent on the formation of new blood and/or lymph vessels. Furthermore, metastases often disperse via newly formed blood or lymphatic vessels within the tumor, particularly in the case of epithelium-derived tumors. Since vascular endothelial growth factor (VEGF) signaling plays a vital role in angiogenesis and lymphangiogenesis, we used the small interfering RNA (siRNA) approach to selectively down-regulate VEGF-A, VEGF-C or VEGF receptor 3 (VEGFR-3) expression in bladder transitional carcinoma cells derived from T739 mice in an attempt to suppress tumor growth and metastasis in vivo. The synthetic siRNA was introduced into the tumor tissues by in vivo electroporation. The knockdown of VEGF-A, VEGF-C and VEGFR-3 expression significantly delayed tumor growth and reduced tumor metastasis compared to the negative controls. Thus, electroporation-mediated siRNA delivery to block the VEGF signaling pathway may provide a novel approach for the treatment or prevention of solid tumor growth and metastasis.

Entities:  

Year:  2010        PMID: 22993616      PMCID: PMC3445895          DOI: 10.3892/etm.2010.113

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  19 in total

Review 1.  Post-transcriptional gene silencing by double-stranded RNA.

Authors:  S M Hammond; A A Caudy; G J Hannon
Journal:  Nat Rev Genet       Date:  2001-02       Impact factor: 53.242

Review 2.  RNA interference and chemically modified small interfering RNAs.

Authors:  Muthiah Manoharan
Journal:  Curr Opin Chem Biol       Date:  2004-12       Impact factor: 8.822

3.  A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.

Authors:  Hui Guan; Zhichao Zhou; Hua Wang; Shu-Fang Jia; Wenbiao Liu; Eugenie S Kleinerman
Journal:  Clin Cancer Res       Date:  2005-04-01       Impact factor: 12.531

4.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.

Authors:  A Fire; S Xu; M K Montgomery; S A Kostas; S E Driver; C C Mello
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

5.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

6.  Vascular endothelial growth factor-C expression in bladder transitional cell cancer and its relationship to lymph node metastasis.

Authors:  Xiongbing Zu; Zhengyan Tang; Yuan Li; Ning Gao; Jian Ding; Lin Qi
Journal:  BJU Int       Date:  2006-11       Impact factor: 5.588

Review 7.  siRNA-based approaches in cancer therapy.

Authors:  G R Devi
Journal:  Cancer Gene Ther       Date:  2006-01-20       Impact factor: 5.987

8.  VEGF-targeted RNA interference suppresses angiogenesis and tumor growth of retinoblastoma.

Authors:  R B Jia; P Zhang; Y X Zhou; X Song; H Y Liu; L Z Wang; M Luo; J Lu; S F Ge; X Q Fan
Journal:  Ophthalmic Res       Date:  2007-02-02       Impact factor: 2.892

9.  RNA interference (RNAi)-mediated vascular endothelial growth factor-C (VEGF-C) reduction interferes with lymphangiogenesis and enhances epirubicin sensitivity of breast cancer cells.

Authors:  Ping Sun; Jie Gao; Yan-Li Liu; Lu-Wan Wei; Li-Ping Wu; Zhi-Yu Liu
Journal:  Mol Cell Biochem       Date:  2007-10-16       Impact factor: 3.396

10.  Lymphatic vessel density and function in experimental bladder cancer.

Authors:  Marcia R Saban; Rheal Towner; Nataliya Smith; Andrew Abbott; Michal Neeman; Carole A Davis; Cindy Simpson; Julie Maier; Sylvie Mémet; Xue-Ru Wu; Ricardo Saban
Journal:  BMC Cancer       Date:  2007-11-29       Impact factor: 4.430

View more
  4 in total

1.  Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization.

Authors:  E Alirahimi; A Ashkiyan; F Kazemi-Lomedasht; K Azadmanesh; M Hosseininejad-Chafi; M Habibi-Anbouhi; R Moazami; M Behdani
Journal:  Cancer Gene Ther       Date:  2016-12-16       Impact factor: 5.987

Review 2.  Targeted therapies in bladder cancer: an overview of in vivo research.

Authors:  Kim E M van Kessel; Tahlita C M Zuiverloon; Arnout R Alberts; Joost L Boormans; Ellen C Zwarthoff
Journal:  Nat Rev Urol       Date:  2015-09-22       Impact factor: 14.432

3.  AEG-1 Promotes Metastasis Through Downstream AKR1C2 and NF1 in Liver Cancer.

Authors:  Cong Li; Xia Wu; Wei Zhang; Jia Li; Huawei Liu; Ming Hao; Junsong Wang; Honghai Zhang; Gengxia Yang; Meijun Hao; Shoupeng Sheng; Yu Sun; Jiang Long; Xiongbing Hu; Hanshuo Zhang; Caixia Hu; Li Li; Jiasheng Zheng
Journal:  Oncol Res       Date:  2014       Impact factor: 5.574

4.  Sulfated polysaccharide of Sepiella maindroni ink targets Akt and overcomes resistance to the FGFR inhibitor AZD4547 in bladder cancer.

Authors:  Liping Shan; Wei Liu; Yunhong Zhan
Journal:  Aging (Albany NY)       Date:  2019-09-23       Impact factor: 5.682

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.